COMMUNIQUÉS West-GlobeNewswire

Teva and Sanofi Present New Positive Phase 2b Study Results at ECCO 2025 Reinforcing Best-in-Class Potential of Duvakitug (Anti-TL1A) in Ulcerative Colitis and Crohn’s Disease
22/02/2025
Teva hosting investor call Monday, February 24 at 8:00 a.m. U.S. ET New detailed data from the RELIEVE UCCD study support overall efficacy and safety of duvakitug in all pre-specified subgroups across the different [...]
Iovance Biotherapeutics Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4)
21/02/2025
SAN CARLOS, Calif., Feb. 21, 2025 (GLOBE NEWSWIRE) -- Iovance Biotherapeutics, Inc. (NASDAQ: IOVA) ("Iovance" or the “Company”), a biotechnology company focused on innovating, developing, and delivering novel polyclonal [...]
TELA Bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
21/02/2025
MALVERN, Pa., Feb. 21, 2025 (GLOBE NEWSWIRE) -- TELA Bio, Inc. ("TELA Bio") (NASDAQ: TELA), a commercial-stage medical technology company focused on providing innovative soft-tissue reconstruction solutions, today [...]
eXoZymes and MDB Capital Announce Leadership Transition at eXoZymes Inc.
21/02/2025
Monrovia, CA, Feb. 21, 2025 (GLOBE NEWSWIRE) -- eXoZymes Inc. (NASDAQ: EXOZ, formerly Invizyne Technologies) - a pioneer of AI-engineered enzymes that can transform sustainable feedstock into essential chemicals, [...]
Intelligent Bio Solutions Inc. Announces Closing of $3.0 Million Public Offering of Common Stock and Full Exercise of the Underwriter’s Option to Purchase Additional Shares of Common Stock
21/02/2025
NEW YORK, Feb. 21, 2025 (GLOBE NEWSWIRE) -- Intelligent Bio Solutions Inc. (Nasdaq: INBS) (the “Company”), a medical technology company delivering intelligent, rapid, non-invasive testing solutions, today announced the [...]
Fortrea to Add Erin L. Russell to Board of Directors
21/02/2025
Fortrea and Starboard enter into Cooperation Agreement DURHAM, N.C., Feb. 21, 2025 (GLOBE NEWSWIRE) -- Fortrea (Nasdaq: FTRE), a leading global contract research organization (CRO), today announced that it will appoint [...]
Tevogen Bio’s First Trading Year Efficiency: 600% Higher Market Cap Per Team Member, 79% Insider-Owned
21/02/2025
600% higher market cap per team member when compared to industry average. Source: Mr. Damodaran at the Stern School of Business at NYU . Current ownership breakdown: Insiders 79%; Independent Board Members 1%; Lead [...]
Dogecoin Cash, Inc. (OTC:CBDS) Announces Strategic Expansion of Crypto Holdings with Acquisition of 420 Million Dogecoin Cash ($DOG)
21/02/2025
Update on Preferred Dividend Mesquite, Feb. 21, 2025 (GLOBE NEWSWIRE) -- February 21, 2025 – Mesquite, NV – Dogecoin Cash, Inc., formerly, Cannabis Sativa, Inc. (OTCQB: CBDS) is pleased to announce the execution of a [...]
China SXT Pharmaceuticals, Inc. Announces Share Consolidation
21/02/2025
TAIZHOU, China, Feb. 21, 2025 (GLOBE NEWSWIRE) -- China SXT Pharmaceutics, Inc. (Nasdaq: SXTC) (the “Company” or “SXTC”), a specialty pharmaceutical company focusing on the research, development, manufacturing, [...]
GUERBET : Nombre d'actions et de droits de vote composant le capital de la société au 31 janvier 2025
21/02/2025
GUERBET : Nombre d'actions et de droits de vote composant le capital de la société au 31 janvier 2025 En application de l'article L. 233-8 II du code de commerce et de l'article 222-12-5 du règlement général de l'AMF, [...]
Report on transactions with ALK-Abelló A/S B shares and associated securities by managerial staff
21/02/2025
ALK ( ALKB:DC / OMX: ALK B / AKBLF ): In accordance with article 19 in Regulation (EU) No 596/2014 of 16 April 2014 on market abuse (the Market Abuse Regulation), ALK-Abelló A/S shall report the following transactions [...]
Singular Genomics Announces Closing of Acquisition by Deerfield Management
21/02/2025
SAN DIEGO, Feb. 21, 2025 (GLOBE NEWSWIRE) -- Singular Genomics Systems, Inc. (Nasdaq: OMIC), a company leveraging novel next-generation sequencing (NGS) and spatial multiomics technologies to empower researchers and [...]
Ipsen S.A. publishes its 2024 consolidated financial statements
21/02/2025
Ipsen S.A. - 2024 Consolidated Financial Statements Attachment Ipsen_Consolidated financial statements 2024_EN
Ipsen S.A. publie ses comptes consolidés 2024
21/02/2025
Ipsen S.A. - Etats financiers consolidés 2024 Pièce jointe Ipsen_Comptes Consolidés 2024_FR
Correction: Aino Health year-end report January-December 2024
21/02/2025
Correction: The reason for the correction is that the previous mailing did not contain the attached report. This document in English is a translation of the original in Swedish. In case of any discrepancy, the Swedish [...]
Marius Pharmaceuticals Unveils New Corporate Website and Announces Longevity & Endocrinology Advisory Boards
21/02/2025
RALEIGH, N.C., Feb. 21, 2025 (GLOBE NEWSWIRE) -- Marius Pharmaceuticals , a biopharmaceutical company dedicated to redefining the treatment of testosterone deficiency, is excited to announce the launch of its new [...]
Amwell® makes grants to new employees under inducement plan
21/02/2025
BOSTON, Feb. 21, 2025 (GLOBE NEWSWIRE) -- Amwell ® (NYSE: AMWL), a leading technology-enabled care platform provider, announced that on Feb. 18, Amwell made grants of RSUs covering an aggregate of 16,737 shares of its [...]
Ensho Therapeutics Announces Presentation of Data Highlighting NSHO-101 as a Once-Daily Oral Agent for the Potential Treatment of Inflammatory Bowel Disease at ECCO 2025
21/02/2025
MORRIS PLAINS, N.J., Feb. 21, 2025 (GLOBE NEWSWIRE) -- Ensho Therapeutics, Inc., a privately held, clinical-stage biopharmaceutical company focused on developing breakthrough oral therapies for patients with [...]
Biostax Corp Announces Voluntary Delisting from OTC Pink Market and SEC Deregistration
21/02/2025
ORLANDO, Fla., Feb. 21, 2025 (GLOBE NEWSWIRE) -- Biostax Corp (OTC Pink: BIOX) ("Biostax" or "the Company"), a biopharmaceutical company focused on developing innovative immune restoration therapies, today announced its [...]

Pages